ProCE Banner Activity

Adjuvant Treatment of Resected Node-Positive Melanoma With Immune Checkpoint Inhibitors

Slideset Download
Download this expert-authored slideset from a live symposium reviewing best practices in the use of adjuvant immune checkpoint inhibitor therapy for advanced melanoma.

Released: March 29, 2019

Expiration: March 27, 2020

Share

Faculty

Rodabe Amaria

Rodabe Amaria, MD

Assistant Professor
Department of Melanoma Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas

Michael B. Atkins

Michael B. Atkins, MD

Professor of Medicine
Harvard Medical School
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Ahmad Tarhini

Ahmad Tarhini, MD, PhD

Assistant Professor of Medicine
Department of Medicine/Hematology-Oncology
University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Merck Oncology

Faculty Disclosure

Primary Author

Rodabe Amaria, MD

Assistant Professor
Department of Melanoma Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas

Michael B. Atkins, MD

Professor of Medicine
Harvard Medical School
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Ahmad Tarhini, MD, PhD

Assistant Professor of Medicine
Department of Medicine/Hematology-Oncology
University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania